Impact of rivastigmine patch and capsules on activities of daily living in Alzheimer's disease.

@article{Grossberg2011ImpactOR,
  title={Impact of rivastigmine patch and capsules on activities of daily living in Alzheimer's disease.},
  author={George T Grossberg and Xiangyi Meng and Jason T Olin},
  journal={American journal of Alzheimer's disease and other dementias},
  year={2011},
  volume={26 1},
  pages={65-71}
}
BACKGROUND Rivastigmine patches provide similar efficacy to rivastigmine capsules with a lower incidence of gastrointestinal side effects in patients with probable Alzheimer's disease (AD). METHODS Post hoc analysis of a 24-week, prospective, international, randomized, double-blind, placebo- and active-controlled trial. Patients (n = 892) with probable AD received rivastigmine transdermal patches (9.5 mg/24 hours [10 cm(2)]), rivastigmine capsules (6 mg twice daily), or placebo, and impact on… CONTINUE READING

From This Paper

Topics from this paper.
7 Citations
0 References
Similar Papers

Similar Papers

Loading similar papers…